跳至主要内容
临床试验/NCT06410157
NCT06410157招募中不适用

Cardiac-Control Affecting Learning Through Mindfulness (CALM)

University of Southern California1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2025年1月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
240
试验地点
1
主要终点
Change in plasma amyloid-beta 42 levels

研究概览

简要总结

Some types of meditation lead heart rate to become more steady as breathing quiets whereas others lead to large heart rate swings up and down (oscillations) as breathing becomes deeper and slower. The current study is designed to investigate how daily mindfulness practice with heart rate biofeedback during breathing in a pattern that either increases or decreases heart rate oscillation affect attention and memory and blood biomarkers associated with Alzheimer's disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Fluent in English
  • •Black/African-American or White/European-American
  • •Aged between 50-70 years old
  • •Non-pregnant and non-menstruating (for at least the past year)
  • •Have normal or corrected-to-normal vision and hearing
  • •Have reliable access to wifi
  • •Have an email account that you check regularly
  • •Have a phone that receives text messages
  • •Agree to provide blood and urine samples at two campus visits
  • •Agree to devote up to 50 minutes daily to this study for 10 weeks as well as attend two campus visits

排除标准

  • •Have a disorder that would impede performing the breathing intervention (e.g., abnormal cardiac rhythm, arrhythmia, dyspnea)
  • •Have cognitive impairment
  • •Have regularly played Lumosity games in the past 6 months
  • •Have any conditions listed below that are not safe for MRI
  • •*Metal in any parts of your body
  • •Claustrophobia
  • •Have worked as a machinist, metal worker, or in any profession or hobby grinding metal?
  • •Have had an injury to the eye involving a metallic object (e.g., metallic slivers, shavings, or foreign body)
  • •Cardiac pacemaker
  • •Implanted cardiac defibrillator
  • •Aneurysm clip or brain clip
  • •Carotid artery vascular clamp
  • •Neurostimulator
  • •Insulin or infusion pump
  • •Spinal fusion stimulator
  • •Cochlear, otologic, ear tubes or ear implant
  • •Prosthesis (eye/orbital, penile, etc.)
  • •Implant held in place by a magnet
  • •Heart valve prosthesis
  • •Artificial limb or joint
  • •Other implants in body or head
  • •Electrodes (on body, head or brain)
  • •Intravascular stents, filters
  • •Shunt (spinal or intraventricular)
  • •Vascular access port or catheters
  • •Transdermal delivery system or other types of foil patches (e.g., Nitro, Nicotine, Birth control, etc.) that cannot be removed for MRI
  • •Shrapnel, buckshot, or bullets
  • •Tattooed eyeliner or eyebrows
  • •Body piercing(s) that cannot be removed for MRI
  • •Metal fragments (eye, head, ear, skin)
  • •Internal pacing wires
  • •Aortic clips
  • •Metal or wire mesh implants
  • •Wire sutures or surgical staples
  • •Harrington rods (spine)
  • •Bone/joint pin, screw, nail, wire, plate
  • •Wig or toupee that cannot be removed for MRI
  • •Hair implants that involve staples or metal
  • •Hearing aid(s) that cannot be removed for MRI
  • •Dentures or retainers that cannot be removed for MRI

研究组 & 干预措施

Increase Oscillation

Experimental

Participants will breath at a slow "resonance" frequency during a breath-focused mindfulness practice and receive biofeedback to increase heart rate oscillation.

干预措施: Daily practice (Behavioral)

Decrease Oscillation

Experimental

Participants' breathing will not be fixed to particular frequency during a breath-focused mindfulness practice and they will receive biofeedback to decrease heart rate oscillation.

干预措施: Daily practice (Behavioral)

结局指标

主要结局

Change in plasma amyloid-beta 42 levels

时间窗: Week 1 and Week 10

Plasma Ab42 levels will be compared for Week 1 (pre-intervention) and Week 10 (post-intervention). Investigators will test for a time X condition interaction in plasma Ab 42 levels (to assess group differences in change).

次要结局

  • Change in brain perivascular space volume(Week 1 and Week 10)
  • Plasma amyloid-beta 40 levels(Week 1 and Week 10)
  • Plasma Ab42/40 ratio(Week 1 and Week 10)
  • Plasma pTau-181/tTau ratio(Week 1 and Week 10)
  • Brain training performance on Lumosity games during the breathing intervention(During intervention (daily during Weeks 2-10) and before intervention (daily during Week 1))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mara Mather

Professor

University of Southern California

研究点 (1)

Loading locations...

相似试验